We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

16 hedge funds and large institutions have $2.91M invested in Achieve Life Sciences in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

7% more funds holding

Funds holding: 15 → 16 (+1)

0.27% more ownership

Funds ownership: 0.83% → 1.1% (+0.27%)

19% less capital invested

Capital invested by funds: $3.59M → $2.91M (-$679K)

Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$586K
2
SCM
Sio Capital Management
New York
+$364K
3
VF
Virtu Financial
New York
+$210K
4
SC
Searle & Co
Connecticut
+$209K
5
Renaissance Technologies
Renaissance Technologies
New York
+$126K

Top Sellers

Rank Fund Capital Flow
1
WVP
Worth Venture Partners
New Jersey
-$183K
2
Citadel Advisors
Citadel Advisors
Florida
-$7.99K
3
LTFS
Ladenburg Thalmann Financial Services
Florida
-$1.34K
4
Bank of America
Bank of America
North Carolina
-$1K
5
Morgan Stanley
Morgan Stanley
New York
-$424
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sio Capital Management
New York
$1.01M +$364K +5,147 +24%
Renaissance Technologies
2
Renaissance Technologies
New York
$620K +$126K +1,780 +12%
Vanguard Group
3
Vanguard Group
Pennsylvania
$530K +$586K +8,283 +152%
SC
4
Searle & Co
Connecticut
$256K +$209K +2,955 +80%
WVP
5
Worth Venture Partners
New Jersey
$139K -$183K -2,594 -42%
VF
6
Virtu Financial
New York
$115K +$210K +2,973 New
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$71K – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$68K – – –
Jane Street
9
Jane Street
New York
$32K +$59.5K +842 New
Citadel Advisors
10
Citadel Advisors
Florida
$28K -$7.99K -113 -14%
Deutsche Bank
11
Deutsche Bank
Germany
$19K +$35.5K +502 +5,020%
BlackRock
12
BlackRock
New York
$17K – – –
JP Morgan Chase
13
JP Morgan Chase
New York
$2K +$4.24K +60 New
FDCDDQ
14
Federation des caisses Desjardins du Quebec
Quebec, Canada
$156 – – –
LTFS
15
Ladenburg Thalmann Financial Services
Florida
– -$1.34K -19 Closed
Bank of America
16
Bank of America
North Carolina
– -$1K -13 Closed
Morgan Stanley
17
Morgan Stanley
New York
– -$424 -6 -75%
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
– -$71 -1 -50%

ACHV Hedge Fund Activity: Q2 2019 in Review

16 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2019, worth a combined $2.91M — down 19% from $3.59M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ACHV positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $586K. The largest seller was Worth Venture Partners, cutting an estimated $183K.

  • 16 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2019, up from 15 in Q1 2019.
  • Funds reported $2.91M of Achieve Life Sciences stock for Q2 2019, down 19% quarter-over-quarter.
  • 3 funds opened new Achieve Life Sciences positions in Q2 2019 and 2 closed out, a net change of +1 holder.
  • The largest Achieve Life Sciences buyer in Q2 2019 was Vanguard Group, an estimated $586K added.
  • The largest Achieve Life Sciences seller in Q2 2019 was Worth Venture Partners, an estimated $183K sold.

Based on aggregated 13F filings for Q2 2019.